PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7629591-10	1995	Indium-111-antimyosin Fab imaging demonstrated additional myocardial involvement, which supported the initiation of immunosuppressive therapy.	Indium	0-6	FA complementation group B	Homo sapiens	22-25	
7629591-0	1995	Indium-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus.	Indium	0-6	FA complementation group B	Homo sapiens	22-25	
7629591-1	1995	Indium-111-antimyosin Fab imaging has been used to indicate myocardial injury.	Indium	0-6	FA complementation group B	Homo sapiens	22-25	
7629591-5	1995	Indium-111-antimyosin Fab imaging showed myocardial tracer uptake.	Indium	0-7	FA complementation group B	Homo sapiens	22-25	
7957355-3	1994	In myocarditis, indium-111 antimyosin Fab imaging can visualize active myocyte damage and thus contribute substantially to the diagnosis.	Indium	16-22	FA complementation group B	Homo sapiens	38-41	
7779528-0	1995	Indium-111 antimyosin monoclonal antibody Fab imaging in patients with cardiomyopathy.	Indium	0-6	FA complementation group B	Homo sapiens	42-45	
8294997-0	1994	Pulmonary uptake in indium-111-antimyosin Fab fragment imaging following human cardiac transplantation.	Indium	20-27	FA complementation group B	Homo sapiens	42-45	
8218161-8	1993	A novel feature of the In-EOTUBE/Fab" complex is coordination of the indium by N epsilon of one histidine from the heavy chain"s third CDR (distance = 2.4 A).	Indium	69-75	FA complementation group B	Homo sapiens	33-36	
1744720-1	1991	Indium-111-antimyosin Fab scan was performed in patients with hypertrophic and postpartum cardiomyopathies to assess whether or not myocardial damage can be delineated.	Indium	0-7	FA complementation group B	Homo sapiens	22-25	
8511600-6	1993	This review describes the clinical experience with two immunoscintigraphic diagnostic agents specifically designed for the assessment of cardiovascular disorders resulting in the death of myocytes and the formation of acute blood clots indium-111 antimyosin-Fab-diethylenetriamine pentaacetic acid for the detection of myocardial necrosis and technetium-99m antifibrin Fab" (T2G1s) for the detection of acute venous thrombosis.	Indium	236-242	FA complementation group B	Homo sapiens	258-261	
1618229-0	1992	Alterations in an indium-111 Fab" under conditions of utilization.	Indium	18-24	FA complementation group B	Homo sapiens	29-32	
1618229-1	1992	This study was conducted to investigate alterations that occur in an indium/111 Fab" of a monoclonal antibody following its in vivo administration.	Indium	69-75	FA complementation group B	Homo sapiens	80-83	
1754893-6	1991	Preliminary clinical studies in patients with signs or symptoms of DVT have evaluated indium-111 59D8 Fab and technetium-99m T2G1s Fab".	Indium	86-92	FA complementation group B	Homo sapiens	102-105	
3668661-1	1987	Indium-111 monoclonal antimyosin Fab scintigraphy was used to detect myocardial necrosis in 52 of 54 patients (96.3%) with acute myocardial infarction.	Indium	0-6	FA complementation group B	Homo sapiens	33-36	
1850785-0	1991	Myocardial distribution of indium-111-antimyosin Fab in acute inferior and right ventricular infarction: comparison with technetium-99m-pyrophosphate imaging and histologic examination.	Indium	27-34	FA complementation group B	Homo sapiens	49-52